Clinical Trial Update: Adjunctive Treatment for Decreasing Symptoms of Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating adjunctive treatment to reduce schizophrenia symptoms; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2, Phase 3 | Status: COMPLETED